Why It Matters
Transcranial Magnetic Stimulation (TMS) is a noninvasive brain stimulation treatment best known for treating depression. In recent years, researchers have explored whether it might also help improve symptoms of attention-deficit/hyperactivity disorder (ADHD).
Because ADHD is associated with differences in activity in prefrontal brain networks involved in attention and executive functioning, stimulating these regions with TMS may help improve cognitive control.
What Research Studies Show
Several systematic reviews and meta-analyses have examined the effectiveness of repetitive TMS (rTMS) for ADHD. Across studies, rTMS is typically applied to the dorsolateral prefrontal cortex (DLPFC)—a brain region involved in attention, working memory, and impulse control.
The overall findings are fairly consistent: rTMS produces modest but statistically significant improvements in ADHD symptoms.
How TMS Compares to ADHD Medications
While the research is promising, TMS does not currently appear to be as effective as standard ADHD medications.
In general:
Stimulant medications (methylphenidate, amphetamines)
Large effect sizes; about 65–80% of patients improve
Non-stimulant medications (atomoxetine, guanfacine)
Moderate effect sizes; improvement in 40–60% of patients
TMS (based on current studies)
Small to modest improvements in symptoms; response rates vary across studies
In other words, medications remain the most effective evidence-based treatment for ADHD, but TMS may offer modest benefit for some patients.
Where TMS May Fit in ADHD Treatment
TMS may ultimately be most useful for:
Adults who cannot tolerate stimulant medications
Patients with both ADHD and depression
Individuals interested in non-medication approaches
possibly combination treatment (medications + TMS)?
However, TMS is not currently FDA-approved for ADHD, and most experts consider it an experimental or emerging treatment.
My Take
Research suggests that TMS can modestly improve ADHD symptoms by stimulating attention networks in the prefrontal cortex. However, current evidence indicates that the benefits are smaller than those seen with standard ADHD medications, and larger clinical trials are still needed before TMS becomes a mainstream treatment. For now, it is not FDA approved, and therefore not covered by commercial insurers (for ADHD treatment).
Sources:
1. Chen Q, Pan N, Long Y, et al. Noninvasive Brain Stimulation in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Treatment Efficacy and Targeting Strategies. Journal of the American Academy of Child and Adolescent Psychiatry. 2026;65(3):369-391. doi:10.1016/j.jaac.2025.07.009.
2. Han Y, Wei ZY, Zhao N, et al. Transcranial Magnetic Stimulation in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Cortical Excitability and Therapeutic Efficacy. Frontiers in Psychiatry. 2025;16:1544816. doi:10.3389/fpsyt.2025.1544816.
3. Chen YH, Liang SC, Sun CK, et al. A Meta-Analysis on the Therapeutic Efficacy of Repetitive Transcranial Magnetic Stimulation for Cognitive Functions in Attention-Deficit/Hyperactivity Disorders. BMC Psychiatry. 2023;23(1):756. doi:10.1186/s12888-023-05261-2
If you're seeking evaluation or treatment for adult ADHD in the Bay Area, learn more about our approach here.